Abstract Our previous studies showed that renal proximal tubular cells (RPTC) express Ca 21 -independent phospholipase A 2 g (iPLA 2 g) in endoplasmic reticulum (ER) and mitochondria and that iPLA 2 g prevents and/or repairs lipid peroxidation induced by oxidative stress. Our present studies determined the importance of iPLA 2 g in mitochondrial and cell function using an iPLA 2 g-specific small hairpin ribonucleic acid (shRNA) adenovirus. iPLA 2 g expression and activity were decreased in the ER by 24 h and in the mitochondria by 48 h compared with scrambled shRNA adenovirus-treated cells. Lipid peroxidation was elevated by 2-fold at 24 h and remained elevated through 72 h in cells with decreased iPLA 2 g. Using electrospray ionization-mass spectrometry, primarily phosphatidylcholines and phosphatidylethanolamines were increased in iPLA 2 g-shRNA-treated cells. At 48 h after exposure to the iPLA 2 g shRNA, uncoupled oxygen consumption was inhibited by 25% and apoptosis was observed at 72 and 96 h. RPTC with decreased iPLA 2 g expression underwent apoptosis when exposed to a nonlethal concentration of the oxidant tert-butyl hydroperoxide (TBHP). Exposure of control cells to a nonlethal concentration of TBHP induced iPLA 2 g expression in RPTC. These results suggest that iPLA 2 g is required for the prevention and repair of basal lipid peroxidation and the maintenance of mitochondrial function and viability, providing further evidence for a cytoprotective role for iPLA 2 g from oxidative stress. 
Phospholipase A 2 (PLA 2 ) hydrolyzes the sn-2 ester bond of glycerophospholipids. By this mechanism, PLA 2 generates free fatty acids and lysophospholipids, both of which have biological activity. The family of PLA 2 is large, with .20 isoforms that were separated historically into classes based on Ca 21 requirement or localization [cytosolic, secretory, or Ca 21 -independent PLA 2 (iPLA 2 )] and recently into 15 groups based on amino acids utilized for catalysis and other structural and functional similarities (groups I-XV) (1) . The iPLA 2 family consists of at least seven members, with different isoforms being localized to different subcellular compartments, each displaying PLA 2 activity in the absence of Ca 21 (1). PLA 2 is reported to perform diverse functions, including generation of signaling molecules [e.g., arachidonic acid (2), membrane remodeling (3), and protection or repair of membranes from oxidative damage (4) (5) (6) ]. In support of a protective role for PLA 2 , PLA 2 has been hypothesized to participate in the removal of oxidized fatty acids from biological membranes to maintain membrane integrity (7) . Fatty acids at the sn-2 position of glycerophospholipids are preferred targets of reactive oxygen species due to their relatively high degree of unsaturation. van Kuijk et al. (7) proposed that when lipid peroxidation occurs, the oxidized sn-2 fatty acid of phospholipids becomes less hydrophobic and moves closer to the hydrophilic head of the phospholipid. The movement of this fatty acid increases the space between the polar head groups and exposes the sn-2 ester bond to PLA 2 . This phenomenon would result in an apparent preference of certain PLA 2 s for oxidized phospholipids. The cleavage of oxidized fatty acids releases a lysophospholipid, which can be reacylated with a nonoxidized fatty acid by an acyltransferase and reinserted into the membrane, preserving membrane integrity (8) . The oxidized fatty acids can be detoxified through classical glutathione peroxidases, but only after they are released by the action of PLA 2 (9, 10) . Secretory PLA 2 and cytosolic PLA 2 have been used in vitro to test the hypothesis that PLA 2 can act as repair enzymes in synthetic membranes or isolated microsomes (11, 12) , but the native PLA 2 enzyme(s) responsible for the repair of oxidized phospholipids in intact cellular systems has not been identified.
Two members of the iPLA 2 family, iPLA 2 b and iPLA 2 g (groups VIA and VIB, respectively), are reported to protect cells or organelles during oxidative stress (4) (5) (6) . Overexpression of iPLA 2 b in insulinoma cells and CHO cells results in mitochondrial localization of iPLA 2 b and protects against oxidant-induced apoptosis (6) . In primary cultures of rabbit renal proximal tubule cells (RPTCs), inhibition of iPLA 2 g with racemic bromoenol lactone (BEL) potentiated oxidant-induced lipid peroxidation and necrotic cell death (4) . Furthermore, in isolated rabbit renal cortex mitochondria (RCM), pretreatment with the selective iPLA 2 g inhibitor R-BEL (the R-enantiomer of BEL) accelerated Fe 21 -induced lipid peroxidation and mitochondrial swelling (5). In summary, several studies have reported that iPLA 2 enzymes are important mediators of cell and organelle protection from oxidative stress and lipid peroxidation.
The goal of these experiments was to determine the importance of iPLA 2 g in basal mitochondrial and cellular function. Since previous results from our laboratory suggested that the iPLA 2 g isoform protects renal cells and mitochondria from oxidative damage (4, 5), we hypothesized that decreasing iPLA 2 g expression in RPTC would increase lipid peroxidation, impair mitochondrial function, and decrease viability. To test this hypothesis, RPTCs were infected with adenovirus expressing small hairpin ribonucleic acid (shRNA) to decrease the expression of iPLA 2 g. We also examined the sensitivity of these cells to the model oxidant tert-butyl hydroperoxide (TBHP).
EXPERIMENTAL PROCEDURES

Materials
Annexin V-FITC was purchased from Biovision (Mountain View, CA). All other reagents were from Sigma (St. Louis, MO) or reported previously (13, 14) .
Development of the iPLA 2 g shRNA adenovirus An shRNA insert corresponding to the iPLA 2 g small interfering RNA (sense strand, 5′-gcaagcaacuguauuucuutt-3′; Ambion, Austin, TX) was designed using the Insert Design Tool for pSilencer Vectors on the Ambion website (www.ambion.com). This oligonucleotide was used to generate an adenoviral iPLA 2 g shRNA vector using the pSilencer Adeno-CMV system (Ambion) according to the manufacturerʼs protocol. The crude viral lysate was then transferred to the Viral Vector Core Facility at the Medical University of South Carolina for amplification, purification, and titer determination. The negative control adenovirus, Ad-CMV-RNAi, was obtained from Vector Biolabs (Philadelphia, PA).
Isolation of rabbit RPTCs, culture conditions, and adenovirus treatment Rabbit RPTCs were isolated using the iron oxide perfusion method and grown in 35 mm tissue culture dishes under improved conditions as described previously (15) . Confluent monolayers were exposed to either the iPLA 2 g shRNA adenovirus or a negative control scramble shRNA adenovirus at a concentration of 1 3 10 7 plaque-forming units per 35 mm dish for 24 h. After 24 h, the culture medium was changed to normal culture medium and the cells were cultured routinely and processed as described below.
Immunoblot analysis
Immunoblot analysis of the expression of 88 kDa iPLA 2 g in RPTC mitochondrial and endoplasmic reticulum (ER) fractions was performed using an anti-iPLA 2 g antibody as described previously by our laboratory (5) . Heat shock protein 60 was used as a mitochondrial marker and loading control for mitochondrial samples.
Measurement of iPLA 2 activity
PLA 2 activity was determined under linear reaction conditions in RPTC mitochondrial and ER fractions as described previously (5) . Activity was measured using synthetic (16:0, [ 3 H]20:4) plasmenylcholine (100 mM) in the presence of 4 mM EGTA.
Measurement of apoptosis
Annexin V and propidium iodide (PI) staining were determined using flow cytometry as described previously by our laboratory (16) . RPTCs were washed, fixed, and stained with 4′,6-diamidino-2-phenylindole (DAPI) as described previously (16) . At least 200 nuclei were counted for each treatment group in each experiment.
Measurement of oxygen consumption
RPTC monolayers were washed and gently detached from the dishes with a rubber policeman, suspended in 37°C culture medium, and transferred to the oxygen consumption (QO 2 ) measurement chamber. QO 2 was measured polarographically using a Clark-type electrode as described previously (14, 17) . For measurement of uncoupled QO 2 , 1 mM carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) was used.
Measurement of cellular ATP levels
Intracellular ATP levels were measured using the ATP Bioluminescence Assay Kit CLS II (Roche) as described previously (18) .
Measurement of lipid peroxidation
Lipid peroxidation in RPTCs was monitored as the production of malondialdehyde using thiobarbituric acid-reactive substances (TBARS) as described previously (4) .
Measurement of cellular phospholipids by electrospray ionization-mass spectrometry
At the end of the experimental period, culture media were removed from the dishes, the monolayers were rinsed with 1 ml of phosphate-buffered saline, and the cells were scraped into 1 ml of methanol-water (2.5:1). RPTCs from four dishes were pooled for each experiment. Whole cells were used to identify lipid changes because of the likelihood of lipid mixing during mitochondrial isolation. The cell suspension was then transferred to a glass vial, bubbled extensively with nitrogen, and stored at 280°C until extraction.
Lipids were isolated using a modified method of Bligh and Dyer (19) as described by Zhang, Peterson, and Cummings (20) . Following extraction, the samples were evaporated under a stream of argon gas to near dryness. The lipids were then reconstituted in 95 ml of chloroform-methanol (2:1) and 5 ml of 1 mg/ml deuterated palmitate (m/z 259.5) in chloroform-methanol (2:1), as an internal standard for ESI-MS. Total lipid phosphorus was measured in each sample using malachite green (21) , and the samples were diluted to 5 nmol/ml total lipid phosphorus in chloroform-methanol (2:1). ESI-MS was performed as described previously (20) using a Trap XCT ion-trap mass spectrometer (Agilent Technologies, Santa Clara, CA) with a nitrogendrying gas flow rate of 3 l/min at 300°C and a nebulizer pressure of 10 p.s.i. The scanning range was from 100 to 2,200 m/z on 5 ml of sample scanned for 2.5 min with a mobile phase of acetonitrile-methanol-water (2:3:1) in 0.1% ammonium formate.
Phospholipids were analyzed in both positive and negative ion detection modes.
Statistical analysis
Each experiment was performed using RPTCs from a single rabbit and was repeated at least four times. The appropriate ANOVA was performed for each data set using SigmaStat statistical software. Individual means were compared using Fisherʼs protected least significant difference test with P , 0.05 considered indicative of a statistically significant difference among mean values.
To analyze the mass spectrometry data, the m/z peaks were sorted by m/z and aligned to a master list compiled from the Lipid Maps Consortium (www.lipidmaps.org). Values from Lipid Maps were increased by one for positive mode and decreased by one in negative mode. The negative ion mode spectra were first normalized to the deuterated palmitate peak and then, using the central limit theorem, transformed as described previously (22, 23) . Data from the positive mode were first normalized to the mean values of all of the samples and then transformed using the central limit theorem transformation method. After data normalization, the data were analyzed using ANOVA, and when significant effects were found (P , 0.05), individual means were compared using Duncanʼs multiple range test (a 5 0.05). The only comparisons that were considered meaningful were when iPLA 2 g shRNA (24 or 48 h) treatments were significantly different from uninfected control and scrambled shRNA (24 or 48 h). 
RESULTS
Adenoviral shRNA-mediated knock-down of RPTC iPLA 2 g Infection of RPTCs with the iPLA 2 g shRNA adenovirus resulted in ?80% of cells expressing the transgene, as determined by b-galactosidase staining (data not shown). Mitochondrial iPLA 2 g protein expression and activity were reduced by ?40% at 48 h after iPLA 2 g shRNA adenovirus treatment compared with RPTCs exposed to an equivalent amount of scramble shRNA adenovirus (Fig. 1A, C) . Mitochondrial iPLA 2 g protein and activity levels continued to decrease to ?40% of scramble shRNA-treated cell values at 72 and 96 h. No significant changes in expression or activity of iPLA 2 g in noninfected control cells and scramble shRNA adenovirus-treated cells were observed (data not shown). In contrast, protein levels of iPLA 2 g in the ER fraction of RPTC decreased after 24 h (?65% of scramble shRNA) and decreased to ?40% of scramble shRNA at 48, 72, and 96 h after exposure to iPLA 2 g shRNA (Fig. 1B) . ER-iPLA 2 g activity was also decreased (?25%) at 24 h after exposure to the iPLA 2 g shRNA adenovirus, and activity decreased to ?35% of scramble shRNA at 72 and 96 h (Fig. 1D) . In summary, adenovirus-mediated knock-down of iPLA 2 g protein levels and activity occurred in the ER fraction prior to occurring in the mitochondria, but it resulted in similar decreases (60-70%) in both organelles by 72 h.
Knock-down of RPTC iPLA 2 g causes increases in RPTC phospholipids
We determined the effect of iPLA 2 g knock-down on RPTC phospholipids. A total of 267 m/z values were examined for the phospholipids in each ion mode. Of these, one positive and nine negative m/z species were putatively identified as being specifically increased by decreasing the expression of iPLA 2 g ( Table 1 . Specific identification of these phospholipid species will require tandem MS n to identify exactly which they are. In summary, ablation of 60% of cellular iPLA 2 g resulted in the increase of several specific cellular phospholipids of the phosphatidylcholine, phosphatidylethanolamine, and phosphatidylglycerol classes.
Knock-down of iPLA 2 g increases RPTC lipid peroxidation
Previous studies from our laboratory demonstrated that inhibition of iPLA 2 g led to increased oxidant-induced lipid peroxidation in RPTCs (4) and in isolated renal mito- in RPTCs and whole cell lipids were isolated using a modified Bligh and Dyer (19) method. Phospholipids were identified using ESI-MS in both positive and negative ion modes. Data were normalized using the central limit theorem as described in Experimental Procedures and are presented as means 6 SEM from four or five different rabbits. Within lipid species, means with the same letters were not significantly different as determined by Duncanʼs multiple range test. Where SEM is equal to zero, the particular lipid species was not identified by ESI-MS in any of the samples from that treatment. Boldface values are statistically significant within that particular phospholipid.
chondria (5) . Accordingly, RPTC lipid peroxidation was measured in RPTCs after exposure to the scramble or iPLA 2 g shRNA adenovirus or diluent (control) using the TBARS assay (Fig. 2) . Lipid peroxidation was elevated by ?2-fold at 24 h after exposure to the iPLA 2 g shRNA adenovirus compared with control or scramble shRNA adenovirus (Fig. 2) . TBARS remained elevated by 2-fold above control through 72 h. These results indicate that knocking down iPLA 2 g in RPTCs increases lipid peroxidation prior to the onset of cell death.
Knock-down of RPTC iPLA 2 g causes changes in cellular and nuclear morphology and apoptosis Light microscopy revealed that knock-down of iPLA 2 g resulted in RPTC cell death at 72 and 96 h (Fig. 3) . (Fig. 3) . The cell death observed consisted of RPTC shrinkage and detachment of cells from the plate. Examination of control (data not shown) and scramble shRNA-treated RPTC nuclear morphology, using the nuclear stain DAPI, revealed diffuse nuclear staining consistent with healthy RPTC. In contrast, 72 and 96 h after iPLA 2 g shRNA exposure, RPTC nuclei were condensed (15-20%) or fragmented (4-6%) (Figs. 3, 4) .
Annexin V-FITC and PI staining coupled with flow cytometry was used as an additional marker of apoptosis after knock-down of iPLA 2 g in RPTC. Annexin V-FITC binds to externalized phosphatidyserine on apoptotic cells, while PI stains the DNA of necrotic cells. Beginning at 72 h after iPLA 2 g shRNA adenovirus exposure and persisting at 96 h, annexin V staining increased compared with control or scramble shRNA-treated RPTCs (Fig. 4C) . No increases in PI staining were detected in any treatment group at any time point (data not shown). In summary, the data reveal that knock-down of iPLA 2 g in RPTCs results in apoptotic cell death.
Knock-down of RPTC iPLA 2 g inhibits RPTC mitochondrial function
To determine the effect of decreasing iPLA 2 g expression on mitochondrial function in RPTCs, basal and uncoupled QO 2 rates and ATP levels were determined. Uncoupled QO 2 is a measure of the maximum rate that electrons can be shuttled through the electron transport chain. A 25% decrease in basal QO 2 was observed at 96 h after iPLA 2 g shRNA adenovirus exposure compared with scramble shRNA treatment (Fig. 5A) . Uncoupled QO 2 was inhibited by 25% after 48 h and remained inhibited through 96 h in RPTCs with decreased iPLA 2 g expression (Fig. 5B) . No significant changes in basal or uncoupled QO 2 were observed in control or scramble shRNA-treated RPTCs over 96 h (data not shown). Similar to basal QO 2 , cellular ATP levels were reduced at 96 h after iPLA 2 g shRNA exposure (Fig. 5C ).
ER and mitochondrial iPLA 2 activity measurements were correlated with basal mitochondrial QO 2 (Fig. 6A, E) . Uncoupled QO 2 was well correlated over time only with mitochondrial iPLA 2 activity but not with ER iPLA 2 activity (r 2 5 0.920 vs. 0.564, respectively; Fig. 6B, F) . The high correlation between uncoupled QO 2 and mitochondrial PLA 2 activity is consistent with the strong correlation between ATP levels and mitochondrial iPLA 2 g activity (Fig. 6C, G) . Both ER and mitochondrial iPLA 2 activity measurements were correlated with the percentage of apoptotic cells after exposure to the iPLA 2 g shRNA adenovirus (Fig. 6D, H) , suggesting that RPTC iPLA 2 g activity is required for cell viability.
Apoptosis is induced by a nonlethal concentration of TBHP in RPTCs with decreased iPLA 2 g expression
To determine the effect of iPLA 2 g knock-down on sublethal oxidant stress, RPTCs with decreased iPLA 2 g, either in the ER fraction only (at 24 h after infection) or in the mitochondrial and ER fractions (at 48 h after infection), were treated with TBHP (75 mM) or diluent for 3 h. While this concentration of TBHP had no effect on annexin V staining in any treatment group at 24 h after infection (Fig. 7A) in RPTCs exposed to diluent (control) or scramble shRNA for 48 h, it caused a 2-fold increase in annexin V staining in RPTCs with decreased ER and mitochondrial iPLA 2 g expression (Fig. 7B) . No increases in PI staining were detected in any treatment group at any time point (data not shown). In summary, RPTCs with decreased iPLA 2 g undergo apoptosis in the presence of a low concentration of the oxidant TBHP, whereas RPTCs with control levels of iPLA 2 g or a limited decrease in iPLA 2 g protein do not.
Nonlethal oxidative stress induces iPLA 2 g expression in RPTCs
Previous studies from our laboratory and the results of the current study demonstrate that iPLA 2 g is an important protective enzyme in RPTCs during oxidative stress. Accordingly, we investigated whether iPLA 2 g expression in RPTC ER and mitochondria is induced in the presence of nonlethal oxidant exposure. RPTCs were exposed to 50 mM TBHP or diluent for 24 h, and the expression of iPLA 2 g was measured by immunoblot analysis (Fig. 8A) . These treatment conditions did not result in RPTC cell death, as confirmed by annexin V and PI staining (data not shown). Twenty-four hours after exposure to 50 mM TBHP, expression of iPLA 2 g was significantly induced (?30%) in both the ER and mitochondria of RPTCs (Fig. 8B) .
DISCUSSION
The development and use of an iPLA 2 g shRNA adenoviral vector in primary cultures of rabbit RPTCs enabled us to examine the role of this enzyme in cell physiology and in the setting of increased oxidative stress. Decreased expression of this enzyme in RPTCs caused an immediate and sustained increase in cellular lipid peroxidation. The increase in peroxidized lipids was followed by a decrease in mitochondrial function and eventually apoptotic cell death. Furthermore, knock-down of iPLA 2 g sensitized RPTCs to nonlethal concentrations of an oxidant. These results support the hypothesis that iPLA 2 g participates in the prevention of oxidation or repair of oxidized phospholipids and highlights the importance of this enzyme in mitochondrial and ER function.
After exposure of RPTCs to iPLA 2 g shRNA, expression of ER-iPLA 2 g decreased by 40% at 24 h. The finding that the 24 h level of mitochondrial iPLA 2 g expression was not different from the control level suggests that the rate of turnover of ER-iPLA 2 g is faster than mitochondrial iPLA 2 g in RPTCs. Furthermore, because cellular lipid peroxidation was significantly elevated at 24 h, we suggest that ER-iPLA 2 g is a vital component of the cellular lipid peroxidation repair pathway in RPTCs. At 48 and 72 h after iPLA 2 g shRNA exposure (when mitochondrial iPLA 2 g expression and activity were decreased by 30-60%), lipid peroxidation remained elevated but did not increase above the 24 h level. Thus, we hypothesize that cells with lipid peroxidation greater than the level observed in the 24 h iPLA 2 g knock-down group underwent cell death and detached from the culture dish.
In this model, we promoted a shift from the physiological condition to a pathological condition by decreasing iPLA 2 g activity through the introduction of shRNA for iPLA 2 g. During the first 48 h, phospholipid changes occurred in the ER and mitochondria, resulting in mitochondrial dysfunction. By 72 h, the cells with decreased iPLA 2 g could not withstand these phospholipid changes (oxidation, phospholipid substrate buildup, etc.) and began to die. Phospholipid changes were not measured once cell death began because of the difficulty in determining whether the phospholipid changes were the result of the loss of iPLA 2 g or were due to the cell death process.
With ESI-MS analysis of the phospholipids, we identified the most classes to be affected. Increased levels of these phospholipids suggested that the loss of iPLA 2 g led to changes in the cellular milieu that affected cellular activity. The transience of these changes likely reflected timedependent differences in the loss of iPLA 2 g between the mitochondria and ER or compensatory changes that occurred over time when other PLA 2 activities possibly became affected.
The loss of iPLA 2 g also resulted in an increase in substrate accumulation: saturated and unsaturated fatty acidcontaining phospholipids. The accumulated unsaturated cellular phospholipids are potential targets of oxidative attack, leading to further damage. This hypothesis is supported by the TBARS data that showed that loss of iPLA 2 g led to greater lipid peroxidation in RPTCs. In addition, changes in saturated fatty acid-containing phospholipids may affect membrane fluidity, affecting organelle functionality.
The effect of iPLA 2 g shRNA on mitochondrial function was most likely the result of decreased mitochondrial iPLA 2 g protein expression, as the loss of mitochondrial function was not observed until 48 h after infection when mitochondrial iPLA 2 g expression and activity were decreased. The initial defect in mitochondrial function was identified at 48 h by determining the maximum capacity of the electron transport chain using the uncoupler FCCP. This stress test revealed a 25% decrease in electron transport capacity without a decrease in basal QO 2 or ATP levels. At 96 h, mitochondrial function was further decreased, as reflected by decreased basal QO 2 and decreased ATP. Because mitochondrial iPLA 2 g is localized to the inner membrane (5), it is likely that the loss of mitochondrial iPLA 2 g resulted in insufficient maintenance of the phospholipid composition or accumulation of oxidized phospholipids in the inner membrane, which, in turn disrupted electron transport. iPLA 2 g may selectively cleave oxidized phospholipids, which are genera t e d b y r e a c t i v e ox y g e n s p e c i es d u ri ng no r m a l oxidative metabolism, in the inner mitochondrial membrane to preserve membrane integrity and prevent the impairment of complex III function (24) . Alternatively, or additionally, iPLA 2 g may be responsible for generating lysocardiolipin, which is reacylated during inner mitochondrial membrane remodeling, a critical process for the optimal function of complexes I, III, and IV of the electron transport chain (25, 26) . In summary, the localization of iPLA 2 g to the inner mitochondrial membrane, the importance of inner mitochondrial membrane phospholipids to the electron transport chain, and our observations that mitochondrial function decreased with decreased iPLA 2 g suggest that iPLA 2 g activity is required to maintain mitochondrial function.
The induced decrease in iPLA 2 g expression resulted in elevated apoptosis, as measured by increased numbers of cells with condensed and fragmented nuclei and annexin V staining at 72 and 96 h. Apoptosis observed under these conditions may be the result of several mechanisms. Lipid peroxidation in the ER may have increased ER Ca 21 permeability, resulting in an elevated cytosolic free Ca 21 concentration that is known to induce apoptosis in this and other models (16, 27) . Ca 21 accumulation by mitochondria may have initiated the mitochondrial permeability transition (MPT), a well-known signal for apoptosis (28) . In addition, mitochondrial lipid peroxidation possibly initiated the MPT and caused the release of apoptotic mediators, including cytochrome c (29), or it may have led to an increase in Ca 21 -dependent PLA 2 activity. Finally, a lipid peroxidation end product, 4-hydroxynonenal, which reportedly induces apoptosis by modulating the activities of Jun and p38 kinases (30, 31) , may have accumulated in RPTCs with decreased iPLA 2 g. In summary, several mechanisms may mediate apoptosis induced by decreased iPLA 2 g.
Upregulation of other lipid peroxidation repair enzymes and/or cellular antioxidants may compensate for the gradual decrease in iPLA 2 g expression. One alternative pathway involves the L-and S-isoforms of phospholipid hydroperoxide glutathione peroxidase (32) . Although phospholipid hydroperoxide glutathione peroxidase can directly reduce peroxidized phospholipids in membranes (33) , its activity has been reported to be up to 500-fold less than that of cytosolic glutathione peroxidase (34) . As mentioned above, the rate-limiting step in cytosolic glutathione peroxidase activity is PLA 2 -mediated hydrolysis of the peroxidized fatty acid. A second potential lipid peroxidation repair enzyme, peroxiredoxin VI, is highly expressed in the lung (35) . It is unknown at this time whether one or both of these pathways are functional in rabbit RPTCs. Upregulation of catalase, superoxide dismutase, or glutathione may also be consequences of iPLA 2 g knock-down. In summary, upregulation of other antioxidant enzymes and molecules may have occurred to compensate for the gradual and prolonged decrease in iPLA 2 g.
In apparent contrast to a previous study in RPTCs demonstrating that pharmacologic inhibition of iPLA 2 g deceases cisplatin-induced apoptosis (36) , knock-down of iPLA 2 g in this study resulted in RPTC apoptosis after oxidant exposure. In the cisplatin-induced RPTC apoptosis model, cell death is not mediated by oxidative stress but by DNA damage and iPLA 2 g-mediated caspase activation (36, 37) . The mechanism by which iPLA 2 g knock-down sensitizes RPTCs to oxidant-induced apoptosis has not been examined, but it may be the result of increased cytosolic Ca 21 due to ER lipid peroxidation and the effect of Ca 21 and lipid peroxidation on mitochondria (inducing MPT), as addressed above. Evidence for opposing roles of iPLA 2 g in RPTCs after oxidant versus nonoxidant insults has accumulated in recent years. For example, in RPTCs and isolated RCM, iPLA 2 g inhibition accelerates oxidantinduced lipid peroxidation, mitochondrial dysfunction, and cell death (4, 5) . In contrast, iPLA 2 g mediates cisplatininduced RPTC apoptosis (36) and Ca 21 -induced MPT in RCM (38) , demonstrating that RPTC iPLA 2 g can be protective or detrimental in oxidant and nonoxidant stress, respectively.
Because all available data regarding the role of iPLA 2 g in oxidant-induced lipid peroxidation, mitochondrial damage, and cell death suggest that iPLA 2 g is part of the RPTC defense against oxidative stress, we hypothesized that its expression would be upregulated in the presence of nonlethal oxidative stress. We confirmed this hypothesis. Additional studies are required to determine the mechanism by which iPLA 2 g expression is increased by oxidative stress and whether iPLA 2 g expression is induced by other sources of oxidative stress.
In conclusion, we demonstrate that selectively decreasing iPLA 2 g expression and activity resulted in increased lipid peroxidation, impaired mitochondrial function, and ultimately apoptotic cell death in RPTCs. Exposure of RPTCs, with decreased expression of iPLA 2 g, to TBHP caused a 2-fold increase in apoptotic cell death, whereas no toxicity was observed in controls. These results are consistent with previous experiments in RPTCs and in isolated RCM showing that pharmacological inhibition of iPLA 2 g increased lipid peroxidation, mitochondrial damage, and cell death induced by oxidants. Furthermore, the expression of iPLA 2 g was increased in both ER and mitochondria as part of the response of RPTCs to oxidative stress. Collectively, these data suggest that iPLA 2 g is a protective enzyme in the kidney under basal conditions and during oxidative stress.
